World's Best Scientists 2026 revealed!
Josep M. Campistol

Josep M. Campistol

D-Index & Metrics

Medicine

D-Index
89
Citations
36169
World Ranking
12517
National Ranking
175

Overview

Josep M. Campistol is affiliated with the University of Barcelona in Spain and has contributed extensively to research within medicine, particularly focusing on transplantation and related clinical studies. Their body of work reflects interdisciplinary expertise in fields such as medicine, biochemistry, genetics, and molecular biology.

Their research spans several main fields, including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Campistol's subfields of study highlight an emphasis on applied medical and biological topics relevant to transplantation and disease, including:

  • Molecular Biology
  • Surgery
  • Transplantation
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Their research covers multiple specialized topics centering around organ transplantation and kidney-related conditions:

  • Renal Transplantation Outcomes and Treatments
  • Organ Transplantation Techniques and Outcomes
  • Organ Donation and Transplantation
  • COVID-19 Clinical Research Studies
  • Renal and related cancers
  • Pregnancy and preeclampsia studies
  • Renal Diseases and Glomerulopathies

Frequent coauthors collaborating with Campistol include:

  • Fritz Diekmann
  • Pedro Ventura-Aguiar
  • María José Ramírez-Bajo
  • Elisenda Bañón-Maneus
  • Ignacio Revuelta

Regular publication venues for their work feature journals with a strong focus on transplantation and rare diseases, such as:

  • American Journal of Transplantation
  • Transplantation
  • Transplant International
  • Orphanet Journal of Rare Diseases
  • Scientific Reports

Notable recent papers authored by or associated with Campistol include:

  • Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? (2020, American Journal of Transplantation)
  • PKU dietary handbook to accompany PKU guidelines (2020, Orphanet Journal of Rare Diseases)
  • A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells (2022, Cell Metabolism)
  • In vivo partial cellular reprogramming enhances liver plasticity and regeneration (2022, Cell Reports)
  • Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single center cohort of kidney recipients (2020, American Journal of Transplantation)

Best Publications

  • Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

    David Adams;Alejandra Gonzalez-Duarte;William D. O'Riordan;Chih Chao Yang

  • Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.

    Carl G. Groth;Lars Bäckman;José-Maria Morales;Roy Calne

  • In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration

    Keiichiro Suzuki;Yuji Tsunekawa;Reyna Hernández-Benítez;Reyna Hernández-Benítez;Jun Wu;Jun Wu

  • Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

    Merrill D. Benson;Márcia Waddington-Cruz;John L. Berk;Michael Polydefkis

  • Tafamidis for transthyretin familial amyloid polyneuropathy A randomized, controlled trial

    Teresa Coelho;Luis F. Maia;Ana Martins da Silva;Marcia Waddington Cruz

  • High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients

    Francisco Maduell;Francesc Moreso;Mercedes Pons;Rosa Ramos

  • In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming

    Alejandro Ocampo;Pradeep Reddy;Paloma Martinez-Redondo;Aida Platero-Luengo

  • Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.

    F. Vincenti;S. Friman;E. Scheuermann;L. Rostaing

  • Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.

    Henri Kreis;Jean-Marc Cisterne;Walter Land;Lars Wramner

  • Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.

    Francesco P. Schena;Michael D. Pascoe;Josefina Alberu;Maria del Carmen Rial

  • Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation

    Sylvie Euvrard;Emmanuel Morelon;Emmanuel Morelon;Lionel Rostaing;Eric Goffin

  • A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)

    A. Durrbach;J. M. Pestana;T. Pearson;F. Vincenti

  • Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation

    Josep M. Campistol;Josette Eris;Rainer Oberbauer;Peter Friend

  • Interspecies Chimerism with Mammalian Pluripotent Stem Cells

    Jun Wu;Aida Platero-Luengo;Masahiro Sakurai;Atsushi Sugawara

  • Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.

    Alex Gutierrez-Dalmau;Josep M Campistol

  • In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.

    Hsin-Kai Liao;Fumiyuki Hatanaka;Toshikazu Araoka;Toshikazu Araoka;Pradeep Reddy

  • SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION

    Carl G. Groth;Maria Morales;Roy Calne;Henri Kreis

  • Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells.

    Yun Xia;Emmanuel Nivet;Ignacio Sancho-Martinez;Thomas Gallegos

  • Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

    Ole B Suhr;Teresa Coelho;Juan Buades;Jean Pouget

  • Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.

    Josep M. Campistol;Alex Gutierrez-Dalmau;J. Vicente Torregrosa

Frequent Co-Authors

Josep M. Grinyó
Josep M. Grinyó University of Barcelona
David H. Adams
David H. Adams Mount Sinai Hospital
Concepcion Rodriguez Esteban
Concepcion Rodriguez Esteban Salk Institute for Biological Studies
Jun Wu
Jun Wu The University of Texas Southwestern Medical Center
Christophe Legendre
Christophe Legendre Necker-Enfants Malades Hospital
Henri Kreis
Henri Kreis Necker-Enfants Malades Hospital
Jordi Rello
Jordi Rello Instituto de Salud Carlos III
Giampaolo Merlini
Giampaolo Merlini University of Pavia
Peter J. Dyck
Peter J. Dyck Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens up many related online degree options and alternative pathways in the healthcare field. For those interested in mental health, online pmhnp programs can fast-track your journey to becoming a Psychiatric Mental Health Nurse Practitioner. These programs often offer flexibility for working professionals or those balancing other commitments.

Students focused on the business side of healthcare may want to consider healthcare administration degrees. These online degrees help develop essential skills for leadership positions in hospitals, clinics, and healthcare organizations, covering topics such as policy, finance, and operations.

Affordability is a key concern for many prospective students. Fortunately, there are cheapest mha programs online healthcare that provide rigorous graduate training at a lower cost, making them accessible to a wider range of learners.

For advanced nursing leadership and clinical roles, students can pursue cheap online dnp programs to earn a Doctor of Nursing Practice. These programs focus on clinical expertise, healthcare innovation, and improved patient outcomes, while offering online convenience.

Best Scientists Citing Josep M. Campistol

Trending Scientists